Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 2 crawled date : 2022 - 01 - 05 save search
Longeveron Announces Initiation of Phase 2a Clinical Trial of Lomecel-B for the Treatment of Alzheimer’s DiseaseTrial designed to obtain safety and efficacy data of single and multiple dosing regimen
Published: 2022-01-05 (Crawled : 15:30) - biospace.com/
LGVN | News P 0 d | $2.005 -4.07% -4.24% 990K
|
|
| O: 21.84%
H: 0.0%
C: 0.0%
alzheimer treatment phase 2 trial disease cel lomecel-b alzheimer’s alzheimer's designation phase 2b
Oncotelic Initiates Phase 1 Trial Evaluating CA4P in Combination with Pembrolizumab for Melanoma
Published: 2022-01-05 (Crawled : 15:00) - biospace.com/
OTLC | $0.0411 -44.63% 21K
|
Manufacturing
|
| O: 0.0%
H: 4.12%
C: -0.88%
trial phase 1 phase 2 phase 3
Longeveron Announces Initiation of Phase 2a Clinical Trial of Lomecel-B for the Treatment of Alzheimer’s Disease
Published: 2022-01-05 (Crawled : 13:30) - globenewswire.com
LGVN | News P 0 d | $2.005 -4.07% -4.24% 990K
|
|
| O: 21.84%
H: 0.0%
C: 0.0%
alzheimer treatment phase 2 trial disease cel lomecel-b alzheimer’s alzheimer's disease alzheimer's phase 2b
VBI Vaccines Announces Dosing of First Patient in Second Phase 2 Study in Chronic Hepatitis B Patients as Part of Expansion of Clinical Collaboration With Brii Bio
Published: 2022-01-05 (Crawled : 13:00) - vbivaccines.com
VBIV | $0.6001 -1.46% -1.48% 180K
|
Health Technology
|
| O: 0.0%
H: 3.86%
C: -6.01%
phase 2 hepatitis expansion collaboration vaccine chronic hepatitis b
Red Pine Updates on its 2022 Phase 1 Drill Program
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
PZG | $0.441 -0.9% 0.0% 54K
|
Non-Energy Minerals
|
| O: 1.45%
H: 8.26%
C: -1.75%
phase 1 phase 2 phase 3 program
Connect Biopharma Reports Detailed Positive Dataset from the Global Phase 2b Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
CNTB | $1.51 -2.58% -2.65% 62K
|
Professional, Scientific, and T...
|
| O: -17.74%
H: 0.0%
C: 0.0%
cbp-201 phase 2 biopharma atopic dermatitis dermatitis phase 2b trial positive
Moderna Announces First Participant Dosed in Phase 1 Study of its mRNA Epstein-Barr Virus (EBV) Vaccine
Published: 2022-01-05 (Crawled : 12:30) - biospace.com/
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
phase 1 vaccine phase 2
Humanigen Announces Target Enrollment in Phase 2/3 ACTIV-5/BET-B Trial of Lenzilumab for the Treatment of COVID-19 has Been Achieved
Published: 2022-01-05 (Crawled : 12:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: -5.81%
H: 0.0%
C: 0.0%
covid-19 treatment phase 2 phase 2/3 lenzilumab trial covid enroll
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.